Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion evidence source_evidence_literature NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion SIO_000772 16973370 NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion wasDerivedFrom befree-20140225 NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion wasGeneratedBy ECO_0000203 NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.